Showing 1 - 3 of 3
In this paper we examine generic competition and market exclusivity periods for pharmaceuticals experiencing their initial generic entry between 1995 and 2005. We find that generic competition has increased over several dimensions. First, an increasing number of drugs are subject to generic...
Persistent link: https://www.econbiz.de/10005443150
Persistent link: https://www.econbiz.de/10007764363
Persistent link: https://www.econbiz.de/10012881705